Trending Stock News

Stockbridge Partners Has Trimmed Stake in Amazon Com (AMZN) as Stock Price Rose; Kistler-Tiffany Companies Has Trimmed Its Holding in West Pharmaceutical Svsc (WST) by $1.10 Million as Shares Declined

Amazon.com, Inc. (NASDAQ:AMZN) Logo

Sharlyn C. Heslam decreased its stake in Amazon Com Inc (AMZN) by 5% based on its latest 2017Q4 regulatory filing with the SEC. Stockbridge Partners Llc sold 6,402 shares as the company’s stock rose 28.13% while stock markets declined. The hedge fund run by Sharlyn C. Heslam held 121,599 shares of the consumer services company at the end of 2017Q4, valued at $142.21 million, down from 128,001 at the end of the previous reported quarter. Stockbridge Partners Llc who had been investing in Amazon Com Inc for a number of months, seems to be less bullish one the $767.51 billion market cap company. The stock decreased 0.35% or $5.52 during the last trading session, reaching $1581.76. About 2.00M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 76.78% since May 18, 2017 and is uptrending. It has outperformed by 65.23% the S&P500.

Kistler-Tiffany Companies Llc decreased its stake in West Pharmaceutical Svsc Inc (WST) by 17.3% based on its latest 2017Q4 regulatory filing with the SEC. Kistler-Tiffany Companies Llc sold 11,240 shares as the company’s stock declined 13.33% with the market. The institutional investor held 53,716 shares of the basic industries company at the end of 2017Q4, valued at $5.30 million, down from 64,956 at the end of the previous reported quarter. Kistler-Tiffany Companies Llc who had been investing in West Pharmaceutical Svsc Inc for a number of months, seems to be less bullish one the $6.51B market cap company. The stock decreased 0.48% or $0.43 during the last trading session, reaching $88.42. About 198,872 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 6.37% since May 18, 2017 and is uptrending. It has underperformed by 5.18% the S&P500.

Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.16, from 1.33 in 2017Q3. It dived, as 19 investors sold WST shares while 97 reduced holdings. 48 funds opened positions while 88 raised stakes. 67.16 million shares or 1.36% less from 68.09 million shares in 2017Q3 were reported. Moreover, Sandhill Cap Prns has 1.82% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 103,611 shares. Ahl Prns Llp holds 22,624 shares or 0.03% of its portfolio. Paloma Prns Mgmt Co has 4,424 shares for 0.01% of their portfolio. 6,778 are held by Fdx Advsrs. Stephens Ar invested 0.01% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Ing Groep Nv accumulated 0% or 2,528 shares. Conestoga Ltd Llc reported 20,993 shares stake. Delta Asset Mgmt Ltd Liability Corp Tn reported 13 shares or 0% of all its holdings. Cwm Ltd Liability Corporation, Nebraska-based fund reported 10 shares. Texas-based Sta Wealth Ltd Llc has invested 0.12% in West Pharmaceutical Services, Inc. (NYSE:WST). Public Employees Retirement Association Of Colorado reported 229,525 shares. Morgan Stanley holds 0.01% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST) for 194,137 shares. Dimensional Fund Advisors Lp has invested 0.01% in West Pharmaceutical Services, Inc. (NYSE:WST). Natixis owns 2,607 shares for 0% of their portfolio. Bancorp Of New York Mellon holds 863,707 shares.

More news for West Pharmaceutical Services, Inc. (NYSE:WST) were recently published by: Streetinsider.com, which released: “West Pharma (WST) Declares $0.14 Quarterly Dividend; to Raises Q4 Dividend 7.1%” on May 03, 2018. Seekingalpha.com‘s article titled: “West Pharmaceutical Services’ (WST) CEO Eric Green on Q1 2018 Results – Earnings Call Transcript” and published on April 26, 2018 is yet another important article.

Among 6 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. West Pharmaceutical Services had 16 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, August 4 by Zacks. The firm has “Hold” rating given on Thursday, June 29 by Jefferies. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) earned “Outperform” rating by Wells Fargo on Friday, October 28. The firm has “Hold” rating by Jefferies given on Tuesday, June 6. On Monday, September 11 the stock rating was maintained by Jefferies with “Hold”. As per Thursday, February 15, the company rating was maintained by Jefferies. Jefferies maintained West Pharmaceutical Services, Inc. (NYSE:WST) on Thursday, July 27 with “Hold” rating. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) has “Outperform” rating given on Tuesday, March 22 by Wells Fargo. Janney Capital initiated West Pharmaceutical Services, Inc. (NYSE:WST) rating on Friday, January 8. Janney Capital has “Buy” rating and $69 target. The firm earned “Hold” rating on Tuesday, October 17 by Bank of America.

Since December 8, 2017, it had 0 buys, and 2 selling transactions for $6.61 million activity.

Kistler-Tiffany Companies Llc, which manages about $559.78M and $253.25 million US Long portfolio, upped its stake in Ishares Tr (IBB) by 4,401 shares to 6,458 shares, valued at $690,000 in 2017Q4, according to the filing. It also increased its holding in Vanguard Whitehall Fds Inc (VYM) by 6,124 shares in the quarter, for a total of 192,146 shares, and has risen its stake in Vanguard Index Fds (VV).

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on July, 26. They expect $0.66 EPS, up 29.41% or $0.15 from last year’s $0.51 per share. WST’s profit will be $48.56 million for 33.49 P/E if the $0.66 EPS becomes a reality. After $0.62 actual EPS reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts 6.45% EPS growth.

Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on July, 26. They expect $2.42 EPS, up 505.00% or $2.02 from last year’s $0.4 per share. AMZN’s profit will be $1.17B for 163.40 P/E if the $2.42 EPS becomes a reality. After $3.27 actual EPS reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts -25.99% negative EPS growth.

Since December 7, 2017, it had 0 insider purchases, and 15 sales for $49.01 million activity. 544 shares valued at $795,502 were sold by Reynolds Shelley on Thursday, February 15. Olsavsky Brian T sold $3.42M worth of stock or 2,333 shares. $1.01 million worth of stock was sold by ALBERG TOM A on Wednesday, February 21. $2.17 million worth of Amazon.com, Inc. (NASDAQ:AMZN) was sold by STONESIFER PATRICIA Q. On Thursday, February 15 Jassy Andrew R sold $2.90 million worth of Amazon.com, Inc. (NASDAQ:AMZN) or 1,985 shares. Zapolsky David also sold $3.24M worth of Amazon.com, Inc. (NASDAQ:AMZN) shares.

Among 55 analysts covering Amazon.com (NASDAQ:AMZN), 52 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 302 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by UBS on Friday, January 29. The company was upgraded on Thursday, August 27 by Raymond James. The firm earned “Buy” rating on Friday, October 27 by Loop Capital. On Thursday, February 18 the stock rating was upgraded by Canaccord Genuity to “Buy”. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Overweight” rating given on Friday, August 28 by Morgan Stanley. The firm has “Buy” rating given on Monday, November 28 by Citigroup. The rating was maintained by Barclays Capital on Tuesday, December 1 with “Overweight”. On Friday, October 27 the stock rating was maintained by Oppenheimer with “Outperform”. RBC Capital Markets maintained Amazon.com, Inc. (NASDAQ:AMZN) on Friday, July 24 with “Outperform” rating. SunTrust maintained Amazon.com, Inc. (NASDAQ:AMZN) rating on Wednesday, October 5. SunTrust has “Neutral” rating and $850 target.

Investors sentiment increased to 1.29 in Q4 2017. Its up 0.03, from 1.26 in 2017Q3. It is positive, as 69 investors sold AMZN shares while 578 reduced holdings. 168 funds opened positions while 667 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. Condor Capital Mgmt holds 0.06% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 255 shares. Impax Asset Limited Company reported 1.74% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). 8,587 are owned by Asset Mngmt. Natl Mutual Insur Federation Of Agricultural Cooperatives accumulated 0.15% or 7,350 shares. Ameritas Investment Prtnrs holds 1.31% or 25,590 shares. Wasatch holds 1,692 shares. 7,905 are owned by Advisor Ptnrs. 15,992 were accumulated by Dock Street Asset. Zeke Capital Advsrs Ltd Liability Com stated it has 0.94% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). 1,279 are held by Duncker Streett. 655 were reported by Peak Asset Mgmt Ltd Liability Com. 2,577 are held by M&R Mgmt. Fukoku Mutual Life Insurance Company stated it has 0.3% in Amazon.com, Inc. (NASDAQ:AMZN). Moreover, Connor Clark Lunn Inv Management Ltd has 0.38% invested in Amazon.com, Inc. (NASDAQ:AMZN). Benchmark Capital holds 0.2% in Amazon.com, Inc. (NASDAQ:AMZN) or 222 shares.

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Benzinga.com which released: “Despite Solid Walmart Results, Rising Bond Yields Could Be In Focus” on May 17, 2018, also Seekingalpha.com with their article: “Seattle scales back tax on Amazon” published on May 15, 2018, Thestreet.com published: “Amazon’s Assault on Grocery Stores Will Have a Profound Impact on Many” on May 15, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: 247Wallst.com and their article: “Why Blink Charging Shares Exploded” published on May 07, 2018 as well as Livetradingnews.com‘s news article titled: “Amazon.com, Inc. (NASDAQ:AMZN) Stock Consolidating” with publication date: May 17, 2018.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *